Biotech startup Ona Therapeutics raises €1.5M from Sabadell Asabys and joins our client list

Biotech startup Ona Therapeutics raised €1.5M from Sabadell Asabys in May 2019 and joined the Metrix Partners client list. The Barcelona company develops new drugs for the treatment of metastatic cancer.

Biotech startup Ona Therapeutics seed round from Sabadell Asabys

About Ona Therapeutics

Most cancer deaths are caused by metastasis, when cancer spreads from the original tumour to other organs. Treatments that act on the metastatic process itself remain scarce. Ona Therapeutics was created to discover and develop therapeutic biologics that target metastatic cancer, building on research from Barcelona’s biomedical research community. The round was reported by El Referente.

The seed round

Sabadell Asabys is a healthcare venture fund backed by Banco Sabadell. Its seed investment gave the company the capital to advance its research programmes and build its team. A specialist health investor at the earliest stage also helps a biotech startup shape its development plan to what later investors will expect.

From seed to Series A in one year

Ona Therapeutics moved fast. In June 2020, about a year after this round, it closed a €30M Series A with Ysios Capital, Alta Life Sciences, Bpifrance, Fund+ and Asabys. Going from a €1.5M seed to a €30M Series A in twelve months is unusual for a Spanish biotech startup, and reflects both the strength of the science and a well-prepared financing process.

What Metrix provides to a biotech startup

  • Financial planning by research milestone.
  • Applications and reporting for public grants and loans.
  • Management accounts and investor reporting.
  • Preparation of the financial case and data room for the next round.
  • Support through investor due diligence.

Five lessons for a biotech startup at seed stage

  1. Define the next milestone. Seed money should reach a clear data point that justifies a Series A.
  2. Choose specialist investors. Health-focused funds bring networks and credibility with later investors.
  3. Combine public and private funding. Spanish programmes such as ENISA and CDTI can extend seed capital.
  4. Secure the IP early. Licences from research institutions must be in place before larger rounds.
  5. Set up finance properly. Clean accounts and grant tracking from the start avoid problems in due diligence.

What founders should prepare for a seed round

  • A research plan with budget and milestones.
  • IP licence agreements and patent filings.
  • A list of grants and loans with their conditions.
  • Accounts reconciled to the statutory filings.
  • A simple cap table with all instruments.

Building a biotech startup in Barcelona

Barcelona combines research centres, hospitals and a growing group of specialist investors. Spin-offs can access local seed funding, public programmes and, increasingly, international venture capital. The challenge is to move from academic research to a company with a development plan investors can fund. Finance and governance from the start make that step easier.

Metrix Partners in life sciences

Metrix supports life sciences clients including Accure Therapeutics, Aelix Therapeutics and Psious.